The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
HER-2/neu Amplification Is an Independent Prognostic Factor in Gastric Cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500 · cited 1×
“In these patients, treatment with Herceptin has been determined to reduce the volume of tumors, to augment chemotherapeutic effects, and to enhance survival rates in both primary and metastatic breast cancer patients [6, 7].”
BackgroundStudies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Isaacson, P. G., Dogan, A., Price, S. K., & Spencer, J. (1989) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198912000-00004 · Cited by 1,915
Vogel, C. L., Cobleigh, M. A., Tripathy, D., Gutheil, J. C., Harris, L. N., Fehrenbacher, L., Slamon, D. J., Murphy, M., Novotny, W. F., Burchmore, M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.719 · Cited by 1,860
Coussens, L., Yang-Feng, T. L., Liao, Y.-C., Chen, E., Gray, A., McGrath, J., Seeburg, P. H., Libermann, T. A., Schlessinger, J., Francke, U., et al. (1985) · Science · doi:10.1126/science.2999974 · Cited by 1,814
Akiyama, T., Sudo, C., Ogawara, H., Toyoshima, K., & Yamamoto, T. (1986) · Science · doi:10.1126/science.3012781 · Cited by 796
Pauletti, G., Dandekar, S., Rong, H., Ramos, L., Peng, H., Seshadri, R., & Slamon, D. J. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.21.3651 · Cited by 670
Kraus, M. H., Popescu, N. C., Amsbaugh, S. C., & King, C. R. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb04797.x · Cited by 617
(2011) · Hepatogastroenterology · doi:10.5754/hge11054 · Cited by 558
(1996) · PubMed · Cited by 554
TNM Classification of Malignant Tumors.5th ed
Szucs, R. (1998) · Radiology · doi:10.1148/radiology.207.1.66 · Cited by 448
Yonemura, Y., Ninomiya, I., Yamaguchi, A., Fushida, S., Kimura, H., Ohoyama, S., Miyazaki, I., Endou, Y., Tanaka, M., & Sasaki, T. (1991) · PubMed · Cited by 375
Kaptain, S., Tan, L. K., & Chen, B. (2001) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200109000-00001 · Cited by 208
Interpretation and Quantification of Immunostains
Seidal, T., Balaton, A. J., & Battifora, H. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200109000-00013 · Cited by 205
Hollywood, D. P., & Hurst, H. C. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05891.x · Cited by 136
Cohen, J. A., WEINER, D. B., Kf, M., Kokai, Y., Williams, W. V., Hc, M., Va, L., & Mi, G. (1989) · PubMed · Cited by 110
Ishikawa, T., Kobayashi, M., Mai, M., Suzuki, T., & Ooi, A. (1997) · Europe PMC (PubMed Central) · Cited by 95
Double immunostaining for c-erbB-2 and p53 in human stomach cancer cells
Sasano, H., Date, F., Imatani, A., Asaki, S., & Nagura, H. (1993) · Human Pathology · doi:10.1016/0046-8177(93)90236-a · Cited by 83
The prognostic value of serum and immunohistochemical tumour markers in advanced gastric cancer
Webb, A., Scott-Mackie, P., Cunningham, D., et al. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00504-8 · Cited by 72
Prediction of the Gastric Cancer Mortality in 2000 in Japan
Watanabe, S., Tsugane, S., & Ohno, Y. (1988) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1988.tb01611.x · Cited by 18
Amplification of the c‐erbB‐2 gene detected by FISH in gastric cancers
Satō, T., Abe, K., Kurose, A., Uesugi, N., Todorokl, T., & Sasakl, K. (1997) · Pathology International · doi:10.1111/j.1440-1827.1997.tb03737.x · Cited by 10
Amplification and over-expression of erbB-2 oncogene in primary human breast tumors
Joh, J., Noh, D., Bae, C., Choi, K.-J., & Park, J.-B. (1996) · Experimental & Molecular Medicine · doi:10.1038/emm.1996.8 · Cited by 5
Self-citation
Cited by
Trastuzumab — Mechanism of Action and Use in Clinical Practice
Hudis, C. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmra043186 · Cited by 2,585
Van Cutsem, E., Sagaert, X., Topal, B., Haustermans, K., & Prenen, H. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30354-3 · Cited by 1,793
HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
Gravalos, C., & Jimeno, A. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn169 · Cited by 1,184
Mechanisms of receptor tyrosine kinase activation in cancer
Du, Z., & Lovly, C. M. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0782-4 · Cited by 1,066
Satoh, T., Xu, R.-H., Chung, H. C., Sun, G.-P., Doi, T., Xu, J.-M., Tsuji, A., Omuro, Y., Li, J., Wang, J.-W., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.6136 · Cited by 624
Metadata
- Authors
- Park, D. I., Yun, J. W., Park, J. H., Oh, S. J., Kim, H. J., Cho, Y. K., Sohn, C. I., Jeon, W. K., Kim, B. I., Yoo, C. H., Son, B. H., Cho, E. Y., Chae, S. W., Kim, E.-J., Sohn, J. H., Ryu, S. H., & Sepulveda, A. R.
- Venue
- Digestive Diseases and Sciences
- Published
- 2006-07-26
- Volume
- 51
- Issue
- 8
- Pages
- 1371-1379
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- OpenAlex
- W2002215779
- Cited by
- 329
- References
- 22
- FWCI
- 5.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.